Klener, Pavel <br/><br/>
TRAIL-induced apoptosis of HL60 leukemia cells: two distinct phenotypes of acquired TRAIL resistance that are accompanied with resistance to TNFalpha but not to idarubicin and cytarabine.  [electronic resource] 

 -  Blood cells, molecules & diseases   
 - 77-84 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1096-0961 
<br/><br/><label>Standard No.: </label>10.1016/j.bcmd.2008.10.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis<br/>Apoptosis Regulatory Proteins--drug effects<br/>Caspases--drug effects<br/>Cell Line, Tumor<br/>Cytarabine--pharmacology<br/>Drug Resistance, Neoplasm<br/>HL-60 Cells<br/>Humans<br/>Idarubicin--pharmacology<br/>Leukemia, Promyelocytic, Acute--metabolism<br/>Mice<br/>Protein Serine-Threonine Kinases--drug effects<br/>Receptors, TNF-Related Apoptosis-Inducing Ligand--drug effects<br/>Receptors, Tumor Necrosis Factor--drug effects<br/>Recombinant Proteins--pharmacology<br/>TNF-Related Apoptosis-Inducing Ligand--pharmacology<br/>Tumor Necrosis Factor-alpha--pharmacology<br/>NF-kappaB-Inducing Kinase